Lingyan Wang
Impact in
-
- interferon and immune responses
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis
- Fungal Biology and Applications
Papers in
- Pharmacology 20
- Microbial Natural Products and Biosynthesis 8
- Fungal Biology and Applications 5
- Co-authors
- Shitao Li (6 shared papers)Martin E. Dorf (3 shared papers)Bishi Fu (2 shared papers)Gui‐Yang Xia (17 shared papers)Yuzhuo Wu (15 shared papers)Sheng Lin (17 shared papers)Jens C. Schwamborn (1 shared paper)Hao Ding (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Blood (3 papers)Journal of Natural Products (3 papers)Acta Pharmaceutica Sinica B (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Lingyan Wang
99 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 125
- Immunology 203
- Pharmacology 120
- Molecular Biology 437
- Cancer Research 95
- Pharmacology 51
Countries citing papers authored by Lingyan Wang
This map shows the geographic impact of Lingyan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Wang more than expected).
Fields of papers citing papers by Lingyan Wang
This network shows the impact of papers produced by Lingyan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Wang. The network helps show where Lingyan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 131 | |
| 2 | 2017 | 54 | |
| 3 | 2023 | 52 | |
| 4 | 2013 | 48 | |
| 5 | 2018 | 41 | |
| 6 | 2019 | 38 | |
| 7 | 2018 | 37 | |
| 8 | 2017 | 35 | |
| 9 | 2020 | 31 | |
| 10 | 2014 | 30 | |
| 11 | 2016 | 30 | |
| 12 | 2023 | 28 | |
| 13 | 2020 | 27 | |
| 14 | 2014 | 24 | |
| 15 | 2018 | 23 | |
| 16 | 2023 | 21 | |
| 17 | 2013 | 21 | |
| 18 | 2018 | 19 | |
| 19 | 2020 | 19 | |
| 20 | 2003 | 18 |
About Lingyan Wang
Lingyan Wang is a scholar working on Molecular Biology, Pharmacology, Public Health, Environmental and Occupational Health, Immunology and Organic Chemistry, having authored 109 papers that have together received 1.1k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (8 papers), Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (6 papers), interferon and immune responses (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Reproductive Biology and Fertility (5 papers), Fungal Biology and Applications (5 papers) and Chemical synthesis and alkaloids (5 papers). The work is most often cited by research in Immunology (203 citations), Pharmacology (120 citations), Molecular Biology (437 citations), Cancer Research (95 citations) and Pharmacology (51 citations). Lingyan Wang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Shitao Li, Martin E. Dorf, Bishi Fu, Gui‐Yang Xia, Yuzhuo Wu, Sheng Lin, Jens C. Schwamborn, Hao Ding, Huan Xia and Yanan Wang. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Blood, Journal of Natural Products, Acta Pharmaceutica Sinica B and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.